Atorvastatin for protease inhibitor-related hyperlipidaemia.
Murillas
J
J
Martín
T
T
Ramos
A
A
Portero
J L
JL
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects; D019258:Saquinavir / Q000009:adverse effects
D000924:Anticholesteremic Agents; D017320:HIV Protease Inhibitors; D006538:Heptanoic Acids; D011758:Pyrroles; D018894:Reverse Transcriptase Inhibitors; D000069059:Atorvastatin; D019258:Saquinavir; D019438:Ritonavir